index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

DHPR α1S Energy Metabolism/drug effects Gene Expression Regulation/drug effects Base Sequence Muscular Dystrophy Mice Dynamin 2 Mitochondrial fission Diseases Inhibitors Multi exon skipping Génomique Myogenesis Dystrophin-EGFP Calcium Homeostasis Activin Receptors Immunoglobulin Fc Fragments/pharmacology Ex-vivo Dystrophine Calcium Channels Liver Mdx mouse Cachexia Dystrophin central domain Morphogenesis NNOS Hepatocellular carcinoma CD38 Muscle Strength Animal/physiopathology CaVβs Molecular docking Long noncoding RNA Invivo CaV subunits Duchenne muscular dystrophy DMD Dystrophin Cardiomyopathie Animals Exon skipping Becker muscular dystrophy BMD Muscular Atrophy Metabolism Clinical trials Delivery CTNNB1 Inbred C57BL BMD Duchenne muscular dystrophy Becker muscular dystrophy Dystrophie Musculaire de Duchenne DMD Cardiomyopathy Muscle development Drp1 Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS LKB1 LncARN Antisense oligonucleotides Molecular Sequence Data Skeletal muscle Multi resolution modeling Muscles/physiopathology Genomic Inbred mdx Dystrophy Duchenne DMD dystrophy Cultured Human Umbilical Vein Endothelial Cells Hear Epigenetics Cells MES MiARN Humans Allele‐specific silencing therapy Becker BMD muscular dystrophy Cell homeostasis Knockout Long QT Autophagy Dystrophie Musculaire de Becker BMD DMD Muscular dystrophy Cell Biology Male Gene expression LncRNA Centronuclear myopathy Myotendinous junction Modificateurs de gènes Cell Line Muscle Muscle Biology DMO Dystrophie musculaire de Becker NAD+ L-Type Multiresolution modeling Gene modifiers